Human disease variants of KATNIP fail to support CILK1 activation and control of primary cilia
Journal of Cell Science · 15.10.2025 · 138 (20)
DOI: 10.1242/jcs.264056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, online erschienen am 30.07.2025. Verfasst von Evan H Carpenter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: Cilia, Retina, Abnormalities, Multiple, Kidney Diseases, Cystic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Virginia Harrison Research Award, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Pathogenic variants in KATNIP (encoding katanin-interacting protein) are linked to Joubert syndrome, a prototypical ciliopathy. KATNIP is a scaffold protein that binds and potentiates ciliogenesis-associated kinase 1 (CILK1) activation and function to control cilia length and frequency. We previously showed that of the three predicted ‘domains of unknown functions’ (DUFs) in KATNIP, the DUF2 domain alone supports binding to CILK1 without activating CILK1. Here, we report three human disease variants of KATNIP with different lengths that exhibit loss of function. The longest variant of KATNIP M1474C, which is truncated near the C-terminus, binds to CILK1 but does not support the activating TDY phosphorylation in CILK1, the phosphorylation of CILK1 substrates, or the restriction of cilia length and ciliation rate. Deletion analysis of KATNIP further revealed that residues 1524–1573 encompassing predicted β-sheets and an α-helix are essential for CILK1 activation and function. The results support a model where KATNIP uses separate domains to bind and to enhance activation of CILK1, enabling CILK1 function in control of cilia formation and elongation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
ORCID-Profile: Zheng Fu
Förderung
- University of Virginia Harrison Research Award
- NCI NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Cancer Institute
Zitieren
APA
Carpenter, E. H., Chu, C. Y., Limerick, A., Brautigan, D. L., & Fu, Z. (2025). Human disease variants of KATNIP fail to support CILK1 activation and control of primary cilia. Journal of Cell Science, 138(20). https://doi.org/10.1242/jcs.264056
Vancouver
Carpenter EH, Chu CY, Limerick A, Brautigan DL, Fu Z. Human disease variants of KATNIP fail to support CILK1 activation and control of primary cilia. Journal of Cell Science. 2025;138(20). doi:10.1242/jcs.264056
BibTeX
@article{Carpenter2025,
author = {Carpenter, Evan H and Chu, Cheuk Ying and Limerick, Ana and Brautigan, David L and Fu, Zheng},
title = {Human disease variants of KATNIP fail to support CILK1 activation and control of primary cilia},
journal = {Journal of Cell Science},
year = {2025},
volume = {138},
number = {20},
doi = {10.1242/jcs.264056}
}
EUVIMED